Sign Up to like & get
recommendations!
2
Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.899068
Abstract: Immunotherapies targeting the “don’t eat me” myeloid checkpoint constituted by CD47 SIRPα interaction have promising clinical potential but are limited by toxicities associated with the destruction of non-tumor cells. These dose-limiting toxicities demonstrate the need…
read more here.
Keywords:
combination trogocytosis;
cd47 sirp;
anti cd47;
cd47 ... See more keywords